Drug Profile
Pregnenolone
Alternative Names: NBI 113Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Neurocrine Biosciences
- Class Antidementias; Corticosteroids; Neuroprotectants; Pregnenes; Progesterone congeners; Small molecules
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 04 Dec 1998 No-Development-Reported for Alzheimer's disease in USA (Unknown route)
- 17 Jan 1996 Preclinical information has been added to the pharmacodynamics section
- 18 May 1995 Phase-II clinical trials for Alzheimer's disease in USA (Unknown route)